Multiplex cytokine profiling in patients with sepsis

APMIS

Volumn 119, Issue 2, 2011, Pages 155-163

  Mera, Simona ^a,b   Tatulescu, Doina ^a,b   Cismaru, Cristina ^a,b   Bondor, Cosmina ^c   Slavcovici, Adriana ^a,b   Zanc, Virginia ^a,b   Carstina, Dumitru ^b   Oltean, Mihai ^d  

^a Clinic of Infectious Diseases   (Romania)

^b Infectious Diseases Hospital   (Romania)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cytokines; Inflammation; Multiplex; Sepsis; Shock

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASSAY; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD SAMPLING; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE SYSTEM; MALE; MORTALITY; MULTIPLEX CYTOKINE ASSAY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEPSIS; SEPTIC SHOCK; SURVIVAL; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CHEMOKINE CCL2; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 78650835112     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02705.x     Document Type: Article

References (32)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
2. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001;16:83-96.
3. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;181:176-180.
4. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-778.
5. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992;215:356-362.
6. Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005;23:488-493.
7. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004;11:161-167.
8. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993;103:565-575.
9. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003;10:133-139.
10. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP Jr. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 2004;61:35-39.
11. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000;243:243-255.
12. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007;11:R49.
13. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655.
14. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-710.
15. Sarbinowski R, Arvidsson S, Tylman M, Oresland T, Bengtsson A. Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthesiol Scand 2005;49:191-196.
16. Assicot M, Gendrel D, Carsin H, Raymond J, Guibaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518.
17. Presterl E, Staudinger T, Pettermann M, Lassnigg A, Burgmann H, Winkler S et al. Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 1997;156:825-832.
18. O'Grady NP, Tropea M, Preas HL 2nd, Reda D, Vandivier RW, Banks SM et al. Detection of macrophage inflammatory protein (MIP)-1a and MIP-1b during experimental endotoxemia and human sepsis. J Infect Dis 1999;179:136-141.
19. Lukacs NW, Kunkel SL, Allen R, Evanoff HL, Shaklee CL, Sherman JS et al. Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations. Am J Physiol 1995;268:L856-861.
20. Shukaliak JA, Dorovini-Zis K. Expression of the beta-chemokines RANTES and MIP-1 beta by human brain microvessel endothelial cells in primary culture. J Neuropathol Exp Neurol 2000;59:339-352.
21. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002;13:455-481.
22. Lehmann AK, Halstensen A, Sørnes S, Røkke O, Waage A. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun 1995;63:2109-2112.
23. Adib-Conquy M, Cavaillon JM. Compensatory anti-inflammatory response syndrome. Thromb Haemost 2009;101:36-47.
24. Perry SE, Mostafa SM, Wenstone R, McLaughlin PJ. Low plasma granulocyte-macrophage colony stimulating factor is an indicator of poor prognosis in sepsis. Intensive Care Med 2002;28:981-984.
25. Bossink AW, Paemen L, Jansen PM, Hack CE, Thijs LG, Van Damme J. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 1995;86:3841-3847.
26. Fujishima S, Sasaki J, Shinozawa Y, Takuma K, Kimura H, Suzuki M et al. Serum MIP-1 alpha and IL-8 in septic patients. Intensive Care Med 1996;22:1169-1175.
27. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-679.
28. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006;177:1967-1974.
29. Kox WJ, Volk T, Kox SN, Volk HD. Immunomodulatory therapies in sepsis. Intensive Care Med 2000;26:S124-128.
30. Netea MG, van der Meer JW, van Deuren M, Kullberg BJ. Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol 2003;24:254-258.
31. van der Poll T. Immunotherapy of sepsis. Lancet Infect Dis 2001;1:165-174.
32. Xiao H, Siddiqui J, Remick DG. Mechanisms of mortality in early and late sepsis. Infect Immun 2006;74:5227-5235.